Drug Interactions between pembrolizumab and ramucirumab
This report displays the potential drug interactions for the following 2 drugs:
Interactions between your drugs
No interactions were found between pembrolizumab and ramucirumab. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Pembrolizumab is in the drug class anti-PD-1 monoclonal antibodies.
Pembrolizumab is used to treat the following conditions:
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Carcinoma
- Gastric Cancer
- Head and Neck Cancer
- Hepatocellular Carcinoma
- Hodgkin's Lymphoma
- Melanoma, Metastatic
- Merkel Cell Carcinoma
- Non-Small Cell Lung Cancer
- Primary Mediastinal Large B-cell Lymphoma
- Renal Cell Carcinoma
- Small Cell Lung Cancer
- Solid Tumors
- Squamous Cell Carcinoma
- Urothelial Carcinoma
- Ramucirumab is in the drug class VEGF/VEGFR inhibitors.
- Ramucirumab is used to treat the following conditions:
Drug and food interactions
No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Drug Interaction Classification
|No interaction information available.|